These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36086988)
1. [Cannabinoids for the treatment of chronic pain - an overview of current medical knowledge]. Gras-Ozimek J; Kozińska U; Gras-Ozimek A Pol Merkur Lekarski; 2022 Aug; 50(298):257-261. PubMed ID: 36086988 [TBL] [Abstract][Full Text] [Related]
2. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. Boychuk DG; Goddard G; Mauro G; Orellana MF J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955 [TBL] [Abstract][Full Text] [Related]
3. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis. Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982 [TBL] [Abstract][Full Text] [Related]
4. Safety of Medical Cannabis in Neuropathic Chronic Pain Management. Bennici A; Mannucci C; Calapai F; Cardia L; Ammendolia I; Gangemi S; Calapai G; Griscti Soler D Molecules; 2021 Oct; 26(20):. PubMed ID: 34684842 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Lynch ME; Campbell F Br J Clin Pharmacol; 2011 Nov; 72(5):735-44. PubMed ID: 21426373 [TBL] [Abstract][Full Text] [Related]
6. Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials. Longo R; Oudshoorn A; Befus D Pain Manag Nurs; 2021 Apr; 22(2):141-149. PubMed ID: 33353819 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. McParland AL; Bhatia A; Matelski J; Tian C; Diep C; Clarke H; Kapustin D; Triveda A; Brull R; Singh M Reg Anesth Pain Med; 2023 Apr; 48(4):180-190. PubMed ID: 36598058 [TBL] [Abstract][Full Text] [Related]
8. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes. Modaresi F; Talachian K Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543 [TBL] [Abstract][Full Text] [Related]
10. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy]. Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies]. Petzke F; Enax-Krumova EK; Häuser W Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780 [TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248 [TBL] [Abstract][Full Text] [Related]
13. Role of cannabinoids in the management of neuropathic pain. Martín Fontelles MI; Goicoechea García C CNS Drugs; 2008; 22(8):645-53. PubMed ID: 18601303 [TBL] [Abstract][Full Text] [Related]